Showing results (101-110 of 3,348) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|November 26, 2020
Quantitative Evidence Synthesis Methods for the Assessment of the Effectiveness of Treatment Sequences for Clinical and Economic Decision Making: A Review and Taxonomy of Simplifying AssumptionsRuth A Lewis, Dyfrig Hughes, Alex J Sutton, et al.
Pharmacoeconomics|November 20, 2019
Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival OutcomesCaitlin Smare, Khalid Lakhdari, Justin Doan, et al.
Pharmacoeconomics|January 7, 2020
Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?Donna Rowen, Oliver Rivero-Arias, Nancy Devlin, et al.
Pharmacoeconomics|March 11, 2020
'Mapping' Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare DiseasesMichela Meregaglia, Amanda Whittal, Elena Nicod, et al.
Pharmacoeconomics|January 21, 2020
Talkin' About a Resolution: Issues in the Push for Greater Transparency of Medicine PricesBrendan Shaw, Jorge Mestre-Ferrandiz
Pharmacoeconomics|January 23, 2019
Cost Effectiveness of Inhaled Mannitol (Bronchitol®) in Patients with Cystic FibrosisEmma Warren, Kristen Morgan, Toby J Toward, et al.
Pharmacoeconomics|November 23, 2019
Potential Bias Associated with Modeling the Effectiveness of Healthcare Interventions in Reducing Mortality Using an Overall Hazard RatioFernando Alarid-Escudero, Karen M Kuntz
Pharmacoeconomics|December 15, 2018
Pembrolizumab for Locally Advanced or Metastatic Urothelial Cancer Where Cisplatin is Unsuitable: An Evidence Review Group Perspective of a NICE Single Technology AppraisalShijie Ren, Hazel Squires, Emma Hock, et al.
Pharmacoeconomics|December 15, 2018
Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in ThailandBunchai Chongmelaxme, Pochamana Phisalprapa, Ratree Manthaisong, et al.
Pharmacoeconomics|December 20, 2018
Doxycycline Added to Prednisolone in Outpatient-Treated Acute Exacerbations of COPD: A Cost-Effectiveness Analysis Alongside a Randomised Controlled TrialAureliano Paolo Finch, Patricia van Velzen, Gerben Ter Riet, et al.
Pageof 335